UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas

Proceedings of the National Academy of Sciences - PNAS, 2020-01, Vol.117 (2), p.1129-1138

2020

Volltextzugriff (PDF)

CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors

Nature communications, 2019-09, Vol.10 (1), p.4016-13, Article 4016

2019

Volltextzugriff (PDF)

A large language model for electronic health records

NPJ digital medicine, 2022-12, Vol.5 (1), p.194-194, Article 194

2022

Volltextzugriff (PDF)

Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity

Nature communications, 2020-03, Vol.11 (1), p.1508-12, Article 1508

2020

Volltextzugriff (PDF)

Cancer Vaccine Immunotherapy with RNA-Loaded Liposomes

International journal of molecular sciences, 2018-09, Vol.19 (10), p.2890

2018

Volltextzugriff (PDF)

Infiltrative and drug‐resistant slow‐cycling cells support metabolic heterogeneity in glioblastoma

The EMBO journal, 2018-12, Vol.37 (23), p.n/a

2018

Volltextzugriff (PDF)

Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma

Journal of clinical oncology, 2010-11, Vol.28 (31), p.4722-4729

2010

Volltextzugriff (PDF)

Quantitative characterization of 3D bioprinted structural elements under cell generated forces

Nature communications, 2019-07, Vol.10 (1), p.3029-9, Article 3029

2019

Volltextzugriff (PDF)

Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM

International journal of cancer, 2017-10, Vol.141 (7), p.1434-1444

2017

Volltextzugriff (PDF)

Emerging trends in immunotherapy for pediatric sarcomas

Journal of hematology and oncology, 2019-07, Vol.12 (1), p.78-78, Article 78

2019

Volltextzugriff (PDF)

Precision therapeutic targets for COVID-19

Virology journal, 2021-03, Vol.18 (1), p.66-66, Article 66

2021

Volltextzugriff (PDF)

Manipulation of Innate and Adaptive Immunity through Cancer Vaccines

Journal of Immunology Research, 2017-01, Vol.2017 (2017), p.1-7

2017

Volltextzugriff (PDF)

Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2 + /CX3CR1 + M-MDSCs into the tumor microenvironment in a redundant manner

Frontiers in immunology, 2023-01, Vol.13, p.993444-993444

2023

Volltextzugriff (PDF)

Lin−CCR2+ hematopoietic stem and progenitor cells overcome resistance to PD-1 blockade

Nature communications, 2018-10, Vol.9 (1), p.4313-14, Article 4313

2018

Volltextzugriff (PDF)

Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma

Clinical cancer research, 2016-02, Vol.22 (3), p.582-595

2016

Volltextzugriff (PDF)

Identification of tumor rejection antigens and the immunologic landscape of medulloblastoma

Genome medicine, 2024-08, Vol.16 (1), p.102-19

2024

Volltextzugriff (PDF)

Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma

Proceedings of the National Academy of Sciences - PNAS, 2013-01, Vol.110 (1), p.270-275

2013

Volltextzugriff (PDF)

Translational nanoparticle engineering for cancer vaccines

Oncoimmunology, 2017-10, Vol.6 (10), p.e1290036-e1290036

2017

Volltextzugriff (PDF)

Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockade

Nature communications, 2024-07, Vol.15 (1), p.5871-20, Article 5871

2024

Volltextzugriff (PDF)

An epidermal growth factor receptor variant III–targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme

Molecular cancer therapeutics, 2009-10, Vol.8 (10), p.2773-2779

2009

Volltextzugriff (PDF)

Systemic activation of antigen-presenting cells via RNA-loaded nanoparticles

Oncoimmunology, 2017-01, Vol.6 (1), p.e1256527-e1256527

2017

Volltextzugriff (PDF)

Metabolomics Monitoring of Treatment Response to Brain Tumor Immunotherapy

Frontiers in oncology, 2021-06, Vol.11, p.691246-691246

2021

Volltextzugriff (PDF)

Temozolomide for immunomodulation in the treatment of glioblastoma

Neuro-oncology (Charlottesville, Va.), 2018-11, Vol.20 (12), p.1566-1572

2018

Volltextzugriff (PDF)

mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors

Genome medicine, 2024-01, Vol.16 (1), p.17-19, Article 17

2024

Volltextzugriff (PDF)

Systemic CTLA-4 Blockade Ameliorates Glioma-Induced Changes to the CD4+ T Cell Compartment without Affecting Regulatory T-Cell Function

Clinical cancer research, 2007-04, Vol.13 (7), p.2158-2167

2007

Volltextzugriff (PDF)

1 – 25 von 485

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(455)
Mit Volltextzugriff
(438)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas

CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors

A large language model for electronic health records

Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity

Cancer Vaccine Immunotherapy with RNA-Loaded Liposomes

Infiltrative and drug‐resistant slow‐cycling cells support metabolic heterogeneity in glioblastoma

Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma

Quantitative characterization of 3D bioprinted structural elements under cell generated forces

Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM

Emerging trends in immunotherapy for pediatric sarcomas

Precision therapeutic targets for COVID-19

Manipulation of Innate and Adaptive Immunity through Cancer Vaccines

Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2 + /CX3CR1 + M-MDSCs into the tumor microenvironment in a redundant manner

Lin−CCR2+ hematopoietic stem and progenitor cells overcome resistance to PD-1 blockade

Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma

Identification of tumor rejection antigens and the immunologic landscape of medulloblastoma

Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma

Translational nanoparticle engineering for cancer vaccines

Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockade

An epidermal growth factor receptor variant III–targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme

Systemic activation of antigen-presenting cells via RNA-loaded nanoparticles

Metabolomics Monitoring of Treatment Response to Brain Tumor Immunotherapy

Temozolomide for immunomodulation in the treatment of glioblastoma

mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors

Systemic CTLA-4 Blockade Ameliorates Glioma-Induced Changes to the CD4+ T Cell Compartment without Affecting Regulatory T-Cell Function

Suchergebnisse filtern